Proton pump inhibitors and adverse kidney outcomes during immune checkpoint blockade: time to sound the alarm?
賦活素幫浦抑制劑與免疫檢查點阻斷期間的不良腎臟結果:是時候拉響警報了嗎?
Clin Kidney J 2023-11-03
Proton Pump Inhibitors and Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Hemodialysis Patients: Results from the Japan Dialysis Outcomes and Practice Patterns Study.
質子幫浦抑制劑與血液透析患者對促紅細胞生成劑的低反應性:來自日本血液透析結果和實踐模式研究的結果。
Am J Nephrol 2024-04-04
Association of Proton Pump Inhibitor Use and Immune Checkpoint Inhibitor Mediated Acute Kidney Injury: A Meta-Analysis and a Review of Related Outcomes.
賦形子抑制劑使用與免疫檢查點抑制劑介導的急性腎損傷之關聯:一項荟萃分析及相關結果回顧。
Am J Nephrol 2024-03-12
Efficacy and Safety of Anti-Osteoporotic Agents Across CKD Stages: A Meta-Analysis of Randomized Clinical Trials.
慢性腎臟病各階段抗骨質疏鬆藥物的療效和安全性:隨機臨床試驗的荟萃分析。
Kidney Blood Press Res 2024-07-07
Association between preoperative proton pump inhibitor use and postoperative acute kidney injury in patients undergoing major surgery.
術前使用質子泵抑制劑與接受重大手術患者術後急性腎損傷之間的關聯。
Ren Fail 2024-08-05
Vertebral fractures in patients with CKD and the general population: a call for diagnosis and action.
慢性腎病患者與一般人群的椎骨骨折:呼籲診斷與行動。
Clin Kidney J 2024-08-05